PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Protein Science, Division of Affinity Proteomics, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.\', \'Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.\', \'Department of Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.\', \'Department of Protein Science, Division of Protein Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/infdis/jiab256
?:hasPublicationType
?:journal
  • The Journal of infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33978762
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all